Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00113165
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
244
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Epilepsy, Partial
Interventions
DRUG:
LAMICTAL extended-release
Sponsor
GlaxoSmithKline